FrancophonIA/ELRC3.0 huggingface dataset:
English: Powder vial: Clear, colourless type I glass vial with a butyl rubber stopper and blue flip-off seal.
Croatian: Bočica s praškom: prozirna, bezbojna staklena bočica tip I s čepom od butilne gume i plavom „flipoff“ zaštitnom kapicom.
English: Xolair is also available in vials with 75 mg omalizumab.
Croatian: Xolair je također dostupan u bočicama sa 75 mg omalizumaba.
English: INSTRUCTIONS FOR USE OF XOLAIR PRE-FILLED SYRINGE
Croatian: UPUTE ZA UPORABU XOLAIR NAPUNJENE ŠTRCALJKE
English: In the second double-blind 28week treatment period the difference in rates between treatment groups represented a 63% (rate ratio 0.37, p<0.001) decrease relative to placebo for omalizumab patients.
Croatian: U drugom dvostruko slijepom 28-tjednom razdoblju liječenja razlika u stopama između terapijskih skupina bila je 63%-tno smanjenje (omjer stopa 0,37, p<0,001) kod bolesnika liječenih omalizumabom u odnosu na placebo.
English: Plunger head
Croatian: Glava klipa
English: Finger grips
Croatian: • oticanje ruku
English: AMPOULE LABEL
Croatian: OZNAČIVANJE AMPULE
English: Chronic administration of omalizumab at dose levels of up to 250 mg/kg (at least 14 times the highest recommended clinical dose in mg/kg according to the recommended dosing table) was well tolerated in non-human primates (both adult and juvenile animals), with the exception of a dose-related and agedependent decrease in blood platelets, with a greater sensitivity in juvenile animals.
Croatian: Nečovjekolike vrste primata (i odrasle i mlađe životinje) dobro su podnosile kroničnu primjenu omalizumaba u visokim dozama (sve do 250 mg/kg ) (barem 14 puta veće od najveće preporučene kliničke doze u mg/kg prema tablici s preporučenim dozama) uz izuzetak smanjenja broja trombocita u krvi povezanog s dozom i ovisnog o dobi, uz veću osjetljivost u mlađih životinja.
English: The LS mean was estimated using an ANCOVA model.
Croatian: LS srednja vrijednost (srednja vrijednost dobivena metodom najmanjih kvadrata) bila je procijenjena uporabom modela ANCOVA.
English: - The needle cap of the syringe may contain dry rubber (latex).
Croatian: - Zatvarač igle na štrcaljki može sadržavati suhu gumu (lateks).
English: If you think you may be allergic to any of the ingredients, tell your doctor as you should not use Xolair.
Croatian: Ako mislite da biste mogli biti alergični na bilo koji sastojak lijeka Xolair, obavijestite svog liječnika jer u tom slučaju ne smijete primjenjivati Xolair.
English: Gripping the middle of the blue syringe guard, lift the syringe out of the tray.
Croatian: Držeći sredinu plavog štitnika igle izvadite štrcaljku iz podloška.
English: Syncope, paraesthesia, somnolence, dizziness
Croatian: Manje često sinkopa, parestezija, somnolencija, omaglica
English: INTERMEDIATE CARTON OF MULTIPACKS (WITHOUT BLUE BOX)
Croatian: MEĐUPAKIRANJE VIŠESTRUKIH PAKIRANJA (BEZ PLAVOG OKVIRA)
English: Therefore treatment with this formulation is intended to be administered by a healthcare provider only.
Croatian: Stoga samo zdravstveni radnik smije primjenjivati lijek u ovoj formulaciji.
English: This medicine is used to treat chronic spontaneous urticaria in adults and adolescents (12 years of age and older) who are already receiving antihistamines but whose CSU symptoms are not well controlled by these medicines.
Croatian: Ovaj lijek se koristi za liječenje kronične spontane urtikarije u odraslih i adolescenata (u dobi od 12 i više godina) koji već primaju antihistaminike, ali čiji simptomi kronične spontane urtikarije nisu dobro kontrolirani tim lijekovima.
English: Dispose of the used syringe immediately in a sharps container.
Croatian: Upotrijebljenu štrcaljku odmah bacite u spremnik za oštre predmete.
English: 1 x 2 ml solvent ampoule
Croatian: 1 x 2 ml ampula s otapalom
English: The product may be kept for a total of 4 hours at 25C.
Croatian: Na temperaturi od 25C ovaj se lijek može čuvati ukupno 4 sata.
English: There is no pharmacological reason to expect that commonly prescribed medicinal products used in the treatment of asthma or CSU will interact with omalizumab.
Croatian: Ne postoji farmakološki razlog zbog kojeg bi se mogle očekivati interakcije omalizumaba s lijekovima koji se obično propisuju za liječenje astme ili KSU-a.
English: Severe asthma exacerbations Rate per 28-week period % reduction, p-value for rate ratio
Croatian: Egzacerbacije teške astme Stopa tijekom 28-tjednog perioda % smanjenja, p-vrijednost za omjer stopa
English: Not known (frequency cannot be estimated from the available data) - muscle pain and joint swelling - hair loss
Croatian: Nepoznato (učestalost se ne može procijeniti iz dostupnih podatatka) - bolove u mišićima i oticanje zglobova - gubitak kose
English: Treatment duration, monitoring and dose adjustments Xolair is intended for long-term treatment.
Croatian: Trajanje liječenja, praćenje i prilagođavanje doze
English: Figure 1 shows the mean weekly itch severity score over time in study 1.
Croatian: Slika 1 pokazuje srednji tjedni rezultat za težinu svrbeža tijekom vremena u ispitivanju
English: In patients with asthma, following multiple doses of omalizumab, areas under the serum concentrationtime curve from Day 0 to Day 14 at steady state were up to 6-fold of those after the first dose.
Croatian: U bolesnika s astmom nakon višekratnih doza omalizumaba površine ispod krivulje ovisnosti koncentracije u serumu o vremenu, od dana 0 do dana 14, u stanju dinamičke ravnoteže bile su do 6 puta veće od onih nakon prve doze.
English: Powder vial: Clear, colourless type I glass vial with a butyl rubber stopper and grey flip-off seal.
Croatian: Bočica s praškom: prozirna, bezbojna staklena bočica tip I s čepom od butilne gume i sivom „flip-off“ zaštitnom kapicom.
English: What Xolair looks like and contents of the pack Xolair 75 mg powder and solvent for solution for injection is supplied as a white to off-white powder in a small glass vial together with an ampoule containing 2 ml of water for injections.
Croatian: Xolair 75 mg prašak i otapalo za otopinu za injekciju dolazi kao bijeli do bjelkasti prašak u maloj staklenoj bočici zajedno s ampulom koja sadrži 2 ml vode za injekcije.
English: The needle cap of the syringe may contain dry rubber (latex).
Croatian: Zatvarač igle na štrcaljki može sadržavati suhu gumu (lateks).
English: Not known (frequency cannot be estimated from the available data) - joint pain, muscle pain and joint swelling - hair loss
Croatian: Nepoznato (učestalost se ne može procijeniti iz dostupnih podatatka) - bolove u zglobovima, bolove u mišićima i oticanje zglobova - gubitak kose
English: Your doctor will work out how much Xolair your child needs and how often it needs to be given.
Croatian: Liječnik će izračunati koliko Xolaira Vaše dijete treba primiti i koliko često.
English: Emergency visits Rate per 28-week period % reduction, p-value for rate ratio
Croatian: Odlasci u hitnu pomoć Stopa tijekom 28-tjednog perioda % smanjenja, p-vrijednost za omjer stopa
English: - If you have any further questions, ask your doctor, pharmacist or nurse.
Croatian: - Ako imate dodatnih pitanja, obratite se liječniku,ljekarniku ili medicinskoj sestri.
English: Patients whose baseline IgE levels or body weight in kilograms are outside the limits of the dose table should not be given Xolair.
Croatian: Xolair se ne smije davati bolesnicima čije su početne IgE vrijednosti ili tjelesna težina u kilogramima izvan granica tablice za doziranje.
English: Dose Syringes needed for the dose 75 mg 1 blue
Croatian: Doza Štrcaljke potrebne za dozu 75 mg 1 plava (75 mg)
English: Dose (mg) Number of vials
Croatian: Doza (mg)
English: How to store Xolair
Croatian: Kako primjenjivati Xolair
English: Asthma exacerbations Rate per 28-week period % reduction, p-value for rate ratio
Croatian: Egzacerbacije astme Stopa tijekom 28-tjednog perioda % smanjenja, p-vrijednost za omjer stopa
English: From a microbiological point of view, the medicinal product should be used immediately after reconstitution.
Croatian: S mikrobiološkog stajališta, pripremljenu otopinu treba primijeniti odmah.
English: Xolair is indicated as add-on therapy to improve asthma control in patients with severe persistent allergic asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and frequent daytime symptoms or night-time awakenings and who have had multiple documented severe asthma exacerbations despite daily high-dose inhaled corticosteroids, plus a long-acting inhaled beta2agonist.
Croatian: Xolair je indiciran kao dodatna terapija za poboljšanje kontrole astme u bolesnika s teškom perzistentnom alergijskom astmom koji imaju pozitivan kožni test ili in vitro reaktivnost na cjelogodišnji inhalacijski alergen, kao i česte simptome tijekom dana ili buđenja tijekom noći i koji imaju višestruke dokumentirane teške egzacerbacije astme, usprkos visokim dnevnim dozama inhalacijskih kortikosteroida uz dugodjelujući inhalacijski beta2-agonist.
English: Your doctor will decide how much Xolair you need and how often you will need it.
Croatian: Vaš liječnik će odlučiti koliko Xolaira trebate primiti i koliko često će Vam biti potreban.
English: Dispose of the used syringe immediately in a sharps container (closable, puncture resistant container).
Croatian: Odmah odložite upotrijebljenu štrcaljku u spremnik za oštre predmete (spremnik koji se može zatvoriti i koji igla ne može probiti).
English: Xolair 75 mg solution for injection is available in packs containing 1 pre-filled syringe and in multipacks containing 4 (4 x 1) or 10 (10 x 1) pre-filled syringes.
Croatian: Xolair 75 mg otopina za injekciju dostupna je u pakiranju koje uključuje 1 napunjenu štrcaljku i u višestrukim pakiranjima koja uključuju 4 (4 x 1) ili 10 (10 x 1) napunjenih štrcaljki.
English: BLISTER OF PRE-FILLED SYRINGE
Croatian: BLISTER NAPUNJENE ŠTRCALJKE
English: After reconstitution one vial contains 125 mg/ml of omalizumab (150 mg in 1.2 ml).
Croatian: Nakon pripreme, jedna bočica sadrži 125 mg/ml omalizumaba (150 mg u 1,2 ml).
English: 0.5 ml solution in a pre-filled syringe barrel (type I glass) with staked needle (stainless steel), (type I) plunger stopper and needle cap.
Croatian: 0,5 ml otopine u tijelu napunjene štrcaljke (staklo tip I) s pričvršćenom iglom (nehrđajući čelik), (tip I) čepom klipa i zatvaračem za iglu.
English: LABELLING AND PACKAGE LEAFLET
Croatian: OZNAČIVANJE NA OMOTU VIŠESTRUKIH PAKIRANJA ZAMOTANIH
English: Table 4 Adverse reactions
Croatian: Tablica 4 Nuspojave
English: Discontinuation of omalizumab should be considered in all severe cases with the above mentioned immune system disorders.
Croatian: Kod svih teških slučajeva s gore navedenim poremećajima imunološkog sustava treba razmotriti prekid liječenja omalizumabom.
English: Pack containing 1 vial of powder and 1 ampoule of water for injections, and multipacks containing 4 (4 x 1) vials of powder and 4 (4 x 1) ampoules of water for injections or 10 (10 x 1) vials of powder and 10 (10 x 1) ampoules of water for injections.
Croatian: Pakiranje sadrži 1 bočicu praška i 1 ampulu vode za injekcije, a višestruka pakiranja sadrže 4 (4 x 1) bočice praška i 4 (4 x 1) ampule vode za injekcije ili 10 (10 x 1) bočica praška i 10 (10 x 1) ampula vode za injekcije.
English: After reconstitution one vial contains 125 mg/ml of omalizumab (75 mg in 0.6 ml).
Croatian: Nakon pripreme, jedna bočica sadrži 125 mg/ml omalizumaba (75 mg u 0,6 ml).
English: Xolair is indicated as add-on therapy to improve asthma control in patients with severe persistent allergic asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and who have reduced lung function (FEV1 <80%) as well as frequent daytime symptoms or night-time awakenings and who have had multiple documented severe asthma exacerbations despite daily highdose inhaled corticosteroids, plus a long-acting inhaled beta2-agonist.
Croatian: Xolair je indiciran kao dodatna terapija za poboljšanje kontrole astme u bolesnika s teškom perzistentnom alergijskom astmom koji imaju pozitivan kožni test ili in vitro reaktivnost na cjelogodišnji inhalacijski alergen te koji imaju smanjenu funkciju pluća (FEV1 <80%) kao i česte simptome tijekom dana ili buđenja tijekom noći i koji imaju višestruke dokumentirane teške egzacerbacije astme, usprkos visokim dnevnim dozama inhalacijskih kortikosteroida uz dugodjelujući inhalacijski beta2-agonist.
English: There was no indication that the safety of Xolair was altered with these other commonly used anti-asthma medicinal products.
Croatian: Nije bilo pokazatelja da su ovi drugi, često korišteni lijekovi za astmu promijenili sigurnost Xolaira.
English: Difference in LS means vs. placebo
Croatian: Razlika u LS srednjim vrijednostima naspram placeba
English: Gripping the middle of the purple syringe guard, lift the syringe out of the tray.
Croatian: Držeći sredinu ljubičastog štitnika igle izvadite štrcaljku iz podloška.
English: Xolair 150 mg powder and solvent for solution for injection is available in packs containing 1 vial of powder and 1 ampoule of water for injections, and in multipacks containing 4 (4 x 1) vials of powder and 4 (4 x 1) ampoules of water for injections or 10 (10 x 1) vials of powder and 10 (10 x 1) ampoules of water for injections.
Croatian: Xolair 150 mg prašak i otapalo za otopinu za injekciju je dostupan u pakiranjima koja sadrže 1 bočicu praška i 1 ampulu vode za injekcije, i u višestrukim pakiranjima koja sadrže 4 (4 x 1) bočice praška i 4 (4 x 1) ampule vode za injekcije ili 10 (10 x 1) bočica praška i 10 (10 x 1) ampula vode za injekcije.
English: Xolair can be used in adolescents aged 12 years of age and older, who are already receiving antihistamines but whose CSU symptoms are not well controlled by these medicines.
Croatian: Xolair se može primjenjivati u adolescenata u dobi od 12 i više godina koji već primaju antihistaminike, ali čiji simptomi kronične spontane urtikarije nisu dobro kontrolirani tim lijekovima.
English: What Xolair looks like and contents of the pack Xolair solution for injection is supplied as a clear to slightly opalescent, colourless to pale brownish-yellow solution in a pre-filled syringe.
Croatian: Xolair otopina za injekciju dolazi kao bistra do lagano opalescentna, bezbojna do blijedo smeđkastožute boje otopina u napunjenoj štrcaljki.
English: Your Xolair 150 mg pre-filled syringe
Croatian: Vaša Xolair 150 mg napunjena štrcaljka
English: 1 ml solution in a pre-filled syringe barrel (type I glass) with staked needle (stainless steel), (type I) plunger stopper and needle cap.
Croatian: 1 ml otopine u tijelu napunjene štrcaljke (staklo tip I) s pričvršćenom iglom (nehrđajući čelik), (tip I) čepom klipa i zatvaračem za iglu.
English: In patients at chronic high risk of helminth infection, a placebo-controlled trial showed a slight numerical increase in infection rate with omalizumab that was not statistically significant.
Croatian: U bolesnika s kroničnim visokim rizikom od helmintijaze placebom kontrolirano ispitivanje je pokazalo blago brojčano povećanje stope infekcija uz omalizumab, koje nije bilo statistički značajno.
English: Pack containing 1 pre-filled syringe, and multipacks containing 4 (4 x 1); 6 (6 x 1) or 10 (10 x 1) prefilled syringes.
Croatian: Pakiranje sadrži 1 napunjenu štrcaljku, a višestruka pakiranja sadrže 4 (4 x 1); 6 (6 x 1) ili 10 (10 x 1) napunjenih štrcaljki.
English: Omalizumab studies 1 and 3 Pooled
Croatian: 1., 2. i 3. ispitivanje omalizumaba objedinjeno
English: Xolair 150 mg solution for injection is available in packs containing 1 pre-filled syringe and in multipacks containing 4 (4 x 1), 6 (6 x 1) or 10 (10 x 1) pre-filled syringes.
Croatian: Xolair 150 mg otopina za injekciju dostupna je u pakiranju koje uključuje 1 napunjenu štrcaljku i višestrukim pakiranjima koja uključuju 4 (4 x 1), 6 (6 x 1) ili 10 (10 x 1) napunjenih štrcaljki.
English: You may not see an immediate improvement in your asthma after beginning Xolair treatment.
Croatian: Ublažavanje simptoma astme ne mora nastupiti odmah nakon početka liječenja Xolairom.
English: Talk to your doctor before using Xolair: - if you have kidney or liver problems.
Croatian: Obratite se svom liječniku prije nego primijenite Xolair: - ako imate probleme s bubrezima ili jetrom. - ako imate poremećaj u kojem Vaš vlastiti imunološki sustav napada dijelove Vašeg tijela
English: In patients at chronic high risk of helminth infection, a placebo-controlled trial showed a slight increase in infection rate with omalizumab, although the course, severity, and response to treatment of infection were unaltered.
Croatian: U bolesnika s kroničnim visokim rizikom od helmintijaze placebom kontrolirano ispitivanje je pokazalo blago povećanje stope infekcija uz omalizumab, iako su tijek, težina i odgovor na liječenje infekcije ostali nepromijenjeni.
English: This medicine is used to prevent asthma from getting worse by controlling symptoms of severe allergic asthma in adults, adolescents and children (6 years of age and older) who are already receiving asthma medicine, but whose asthma symptoms are not well controlled by medicines such as high-dose steroid inhalers or beta-agonist inhalers.
Croatian: Ovaj lijek se koristi za sprječavanje pogoršanja astme tako što kontrolira simptome teške alergijske astme u odraslih osoba, adolescenata i djece (u dobi od 6 i više godina) koji već uzimaju lijekove za astmu, ali čiji se simptomi astme ne mogu dobro kontrolirati lijekovima poput inhalacijskih kortikosteroida u visokim dozama ili inhalacijskih beta-agonista.
English: Discard the needle cap. You may see a drop of liquid at the end of the needle.
Croatian: Možda ćete vidjeti kap tekućine na vrhu igle.
English: In allergic patients at chronic high risk of helminth infection, a placebo-controlled trial showed a slight numerical increase in infection rate with omalizumab that was not statistically significant.
Croatian: U bolesnika s alergijom i kroničnim visokim rizikom od helmintijaze placebom kontrolirano ispitivanje je pokazalo blago brojčano povećanje stope infekcija uz omalizumab, koje nije bilo statistički značajno.
English: In patients at chronic high risk of helminth infection, a placebo-controlled trial in allergic patients showed a slight increase in infection rate with omalizumab, although the course, severity, and response to treatment of infection were unaltered.
Croatian: U bolesnika s kroničnim visokim rizikom od helmintijaze placebom kontrolirano ispitivanje u bolesnika s alergijom pokazalo je blago povećanje stope infekcija uz omalizumab, iako su tijek, težina i odgovor na liječenje infekcije ostali nepromijenjeni.
English: Xolair 75 mg solution for injection is supplied in a single-use pre-filled syringe for individual use.
Croatian: Xolair 75 mg otopina za injekciju dolazi u napunjenoj štrcaljki za jednokratnu primjenu i za pojedinačnu uporabu.
English: VIAL LABEL
Croatian: OZNAČIVANJE BOČICE
English: BATCH NUMBER
Croatian: Broj štrcaljki
English: Clear to slightly opalescent, colourless to pale brownish-yellow solution.
Croatian: Bistra do lagano opalescentna, bezbojna do blijedo smeđkasto-žute boje otopina.
English: Xolair 150 mg solution for injection is supplied in a single-use pre-filled syringe for individual use.
Croatian: Xolair 150 mg otopina za injekciju dolazi u napunjenoj štrcaljki za jednokratnu primjenu i za pojedinačnu uporabu.
English: 1 x 150 mg vial
Croatian: 1 x 150 mg bočica
English: Your Xolair 75 mg pre-filled syringe
Croatian: Vaša Xolair 75 mg napunjena štrcaljka
English: Talk to your doctor before you are given Xolair: - if you have kidney or liver problems.
Croatian: Obratite se svom liječniku prije nego Vam primijeni Xolair: - ako imate probleme s bubrezima ili jetrom. - ako imate poremećaj u kojem Vaš vlastiti imunološki sustav napada dijelove Vašeg tijela
English: Xolair can be given to children and adolescents aged 6 years and older, who are already receiving asthma medicine, but whose asthma symptoms are not well controlled by medicines such as high dose steroid inhalers or beta-agonist inhalers.
Croatian: Xolair se može davati djeci i adolescentima u dobi od 6 i više godina, koji već uzimaju lijekove za astmu, ali čiji se simptomi astme ne mogu dobro kontrolirati lijekovima poput inhalacijskih kortikosteroida u visokim dozama ili inhalacijskih beta-agonista.
English: Viewing window Label & expiry date
Croatian: Kontrolni prozorčić naljepnica i rok valjanosti
English: Infections and infestations Uncommon
Croatian: Infekcije i infestacije Manje često faringitis
English: Xolair 150 mg injection omalizumab SC
Croatian: Xolair 150 mg injekcija omalizumab s.c.
English: Total serum IgE levels may be re-tested for dose determination if treatment with Xolair has been interrupted for one year or more.
Croatian: Ukoliko je liječenje Xolairom bilo prekinuto godinu dana ili više, razine ukupnog IgE u serumu mogu se ponovno odrediti radi određivanja doze.
English: IgE plays a key role in causing allergic asthma or CSU.
Croatian: IgE igra ključnu ulogu u pojavi alergijske astme ili kronične spontane urtikarije.
English: Powder: sucrose, L-histidine, L-histidine hydrochloride monohydrate and polysorbate 20.
Croatian: Prašak: saharoza, L-histidin, L-histidinklorid hidrat i polisorbat 20.
English: Xolair 75 mg injection omalizumab SC
Croatian: Xolair 75 mg injekcija omalizumab s.c.
English: Multipack: 4 (4 x 1) pre-filled syringes Multipack: 10 (10 x 1) pre-filled syringes
Croatian: Višestruko pakiranje: 4 (4 x 1) napunjene štrcaljke Višestruko pakiranje: 10 (10 x 1) napunjenih štrcaljki
English: - The other ingredients are sucrose, L-histidine, L-histidine hydrochloride monohydrate and polysorbate 20.
Croatian: - Drugi sastojci su saharoza, L-histidin, L-histidinklorid hidrat i polisorbat 20.
English: Xolair can be used in children and adolescents aged 6 years and older, who are already receiving asthma medicine, but whose asthma symptoms are not well controlled by medicines such as high dose steroid inhalers or beta-agonist inhalers.
Croatian: Xolair se može primjenjivati u djece i adolescenata u dobi od 6 i više godina, koji već uzimaju lijekove za astmu, ali čiji se simptomi astme ne mogu dobro kontrolirati lijekovima poput inhalacijskih kortikosteroida u visokim dozama ili inhalacijskih beta-agonista.
English: In CSU, the safety and efficacy of Xolair in paediatric patients below the age of 12 years have not been established.
Croatian: Kod kronične spontane urtikarije, sigurnost i djelotvornost Xolaira u pedijatrijskih bolesnika ispod 12 godina nije ustanovljena.
English: Dyspeptic signs and symptoms, diarrhoea, nausea Skin and subcutaneous tissue disorders Uncommon
Croatian: Manje često znakovi i simptomi dispepsije, proljev, mučnina Poremećaji kože i potkožnog tkiva Manje često fotosenzibilnost, urtikarija, osip, svrbež
English: Allergic granulomatous vasculitis (i.e. Churg-Strauss syndrome)
Croatian: Churg-Straussov sindrom)
English: Musculoskeletal and connective tissue disorders Rare
Croatian: Poremećaji mišićno-koštanog sustava i vezivnog tkiva Rijetko sistemski eritemski lupus (SLE)
English: Pack containing 1 pre-filled syringe, and multipacks containing 4 (4 x 1) or 10 (10 x 1) pre-filled syringes.
Croatian: Pakiranje sadrži 1 napunjenu štrcaljku, a višestruka pakiranja sadrže 4 (4 x 1) ili 10 (10 x 1) napunjenih štrcaljki.
English: 375 mg 1 blue (75 mg)
Croatian: 375 mg 1 plava (75 mg)
English: Each pre-filled syringe of 0.5 ml solution contains 75 mg of omalizumab*.
Croatian: Svaka napunjena štrcaljka s 0,5 ml otopine sadrži 75 mg omalizumaba*.
English: 525 mg 1 blue (75 mg)
Croatian: 525 mg 1 plava (75 mg)
English: The liquid should be clear to slightly cloudy.
Croatian: Tekućina treba biti prozirna do blago zamućena.
English: Each pre-filled syringe of 1 ml solution contains 150 mg of omalizumab*.
Croatian: Svaka napunjena štrcaljka s 1 ml otopine sadrži 150 mg omalizumaba*.
English: Mean weekly itch severity score
Croatian: Srednji tjedni rezultat za težinu svrbeža
English: Your doctor will decide how much Xolair you need and how often you will be given it.
Croatian: Vaš liječnik će odlučiti koliko Xolaira trebate primiti i koliko često.